title: Origin and functional consequences of the complex I defect in Parkinson's disease.
abstract: The mitochondrial electron transport enzyme NADH:ubiquinone oxidoreductase (complex I), which is encoded by both mitochondrial DNA and nuclear DNA, is defective in multiple tissues in persons with Parkinson's disease (PD). The origin of this lesion and its role in the neurodegeneration of PD are unknown. To address these questions, we created an in vitro system in which the potential contributions of environmental toxins, complex I nuclear DNA mutations, and mitochondrial DNA mutations could be systematically analyzed. A clonal line of human neuroblastoma cells containing no mitochondrial DNA was repopulated with mitochondria derived from the platelets of PD or control subjects. After 5 to 6 weeks in culture, these cytoplasmic hybrid (cybrid) cell lines were assayed for electron transport chain activities, production of reactive oxygen species, and sensitivity to induction of apoptotic cell death by 1-methyl-4-phenyl pyridinium (MPP+). In PD cybrids we found a stable 20% decrement in complex I activity, increased oxygen radical production, and increased susceptibility to 1-methyl-4-phenyl pyridinium-induced programmed cell death. The complex I defect in PD appears to be genetic, arising from mitochondrial DNA, and may play an important role in the neurodegeneration of PD by fostering reactive oxygen species production and conferring increased neuronal susceptibility to mitochondrial toxins.
authors.affiliation: Department of Neurology, University of Virginia Health Sciences Center, Charlottesville 22908, USA.
authors.forename: R H
authors.initials: RH
authors.lastname: Swerdlow
authors.forename: J K
authors.initials: JK
authors.lastname: Parks
authors.forename: S W
authors.initials: SW
authors.lastname: Miller
authors.forename: J B
authors.initials: JB
authors.lastname: Tuttle
authors.forename: P A
authors.initials: PA
authors.lastname: Trimmer
authors.forename: J P
authors.initials: JP
authors.lastname: Sheehan
authors.forename: J P
authors.initials: JP
authors.lastname: Bennett
authors.forename: R E
authors.initials: RE
authors.lastname: Davis
authors.forename: W D
authors.initials: WD
authors.lastname: Parker
mesh_terms: D015655:1-Methyl-4-phenylpyridinium / Q000009:adverse effects; D000368:Aged; D017209:Apoptosis; D016923:Cell Death; D004272:DNA, Mitochondrial; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D018482:Muscle, Skeletal / Q000737:chemistry*; D009243:NAD / Q000032:analysis*; D016660:NAD(P)H Dehydrogenase (Quinone) / Q000502:physiology*; D010300:Parkinson Disease / Q000209:etiology*; D017354:Point Mutation
chemical_list: D004272:DNA, Mitochondrial; D009243:NAD; D016660:NAD(P)H Dehydrogenase (Quinone); D015655:1-Methyl-4-phenylpyridinium